Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN85710690Phase 2Completed
Phase 2, randomised, open-label trial of levobupivacaine in postoperative pain (2 arms), sponsored by Aneurin Bevan University Health Board. Primary endpoint: Pain over first 5 postoperative days. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN85710690.